Jim Tananbaum and a Warm Welcome

Last month, Foresite Capital’s CEO – Jim Tananbaum – had the unique privilege of welcoming Dr. Molly He onboard as a venture partner to Foresight Capital and a potentially invaluable new member. Dr. He formerly directed Illumina and shows much capability in her field of pharmaceutical genomic research. According to Ideamensch, Mr. Tananbaum praises Dr. He as a respected scientific researcher in next-generation sequencing and speaks greatly of his thrill in personally welcoming her on board and of the unspoken possibilities that will commence as a result of the new addition. He claims that she has a proven track record of genomic expertise, drug development research and overall leadership skills and that she’ll serve as a valued resource to Foresight Capital in continuing to expand its portfolio of working partnerships. You can visit his Crunchbase profile for details.

When Dr. He served as senior director of Illumina’s scientific research division, she was responsible for global protein innovation and improvements as well as personally leading the proteins sciences sectors within Pacific Bio-sciences. There, she was specifically responsible for developing the protein regions for single-molecular sequencing chemistry. Prior to that life-changing experience, she worked in the pharmaceutical industry for the last decade and focused on structural-based designs for antibodies and small molecular drugs that target cancer or immune disorders.

Dr. He obtained her bachelor’s degree in biochemistry out of Nankai University as well as her Ph. D. in protein biophysics out of the UCLA. She has authored more than 20 research papers and holds more than 20 patent applications and has even issued patents in next-generation sequencing with personalized medicine. Dr. He later praised Foresight Capital in return, making note of its unparalleled commitment to invest in exciting healthcare opportunities and is thus honored to join the team in moving forward with the best in next-generation research and portfolio initiatives to offer breakthroughs in clinical research as well as drug discovery.https://www.linkedin.com/in/jim-tananbaum-a7562a7/

The Skilled Man Behind the Warm Welcome

Mr. Tananbaum has nearly done it all in his many years within the field.

His top achievements include:

Entrepreneurship

Venture Capital

Private Equity

Investing

Deal-Sourcing

Corporate Development

IPO

Mergers

Biotechnology

Read more: https://drewaltizer.com/event/1163-sfmoma-art-bash-museum-opening-san-francisco-society-art-performances/photo/454808-jim_tananbaum-dana_tananbaum

Leave a Comment

Your email address will not be published. Required fields are marked *